Drug-resistant tuberculosis in Poland in 2000: Second national survey and comparison with the 1997 survey

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 7, 2003, Pages 645-651

  Augustynowicz Kopec, Ewa ^a   Zwolska, Z ^a   Jaworski, A ^a   Kostrzewa, E ^a   Klatt, M ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Acquired resistance; National survey; Poland; Primary resitance; Tubercolosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; INFANT; LABORATORY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; POLAND; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REVIEW;

ADOLESCENT; ADULT; AGED; DATA COLLECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLAND; PREVALENCE; PROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 0038789117     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. World Health Organization, International Union Against Tuberculosis and Lung Disease. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/94.178. Geneva: WHO, 1994.
2. World Health Organization. WHO report on the tuberculosis epidemic. Geneva: WHO, 1997.
3. World Health Organization, International Union Against Tuberculosis and Lung Disease. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Antituberculosis Drug Resistance Surveillance 1994-1997. WHO/TB/97.229. Geneva: WHO, 1997.
4. World Health Organization, International Union Against Tuberculosis and Lung Disease. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/TB/2000.278. Geneva: WHO, 2000.
5. Chaulet P, Boulahbal F, Grosset J. Surveillance of drug resistance for tuberculosis control: why and how. Tubercle Lung Dis 1995; 76: 487-492.
6. Gupta R, Kim J Y, Espinal M A, et al. Responding to marker failures in tuberculosis. Science 2001; 293: 1049-1051.
7. Zwolska Z, Augustynowicz-Kopeć E, Klatt M. Primary and required drug resistance in Polish tuberculosis patients: results of a study of the national drug resistance surveillance programme. Int J Tuberc Lung Dis 2000, 4: 832-838.
8. Zwolska Z, Augustynowicz-Kopeć E, Klatt M. New automated non-radiometric system for the culture of mycobateria MB/BacT and its role in microbiological diagnosis of tuberculosis. Pneumonol Alergol Pol 1998, 66: 24-30.
9. Ellner P, Kiehu T, Cammarata R, Hosmer M. Rapid detection and identification of pathogenic mycobacteria by combining radiometric culture and nucleic acid probe methods. J Clin Microbiol 1988; 26: 1349-1352.
10. Badak F, Goksel S, Sertoz R, et al. Use nucleic acid probes for identification of Mycobacterium tuberculosis directly from MB/BacT bottles. J Clin Microbiol 1999; 37: 1602-1605.
11. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
12. Zierski M. Infection by drug resistant tubercle bacilli in Poland. Tubercle 1962; 43: 382-385.
13. Janowiec M, Zwolska-Kwiek Z, Bek E. Drug resistance in newly discovered untreated tuberculosis patients in Poland 1974-1977. Tubercle 1979; 60: 233-237.
14. Janowiec M, Zwolska-Kwiek Z. Primary drug resistance in patients with pulmonary tuberculosis in Poland in the years 1978-1982. Pneum Pol 1986; 4: 140-143.
15. Szczuka I. Tuberculosis and lung diseases in Poland in 2000. Warsaw: Tuberculosis and Lung Diseases Institute, Department of Epidemiology, 2001.
16. Portaels F, Rigouts L, Bastian I. Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union. Int J Tuberc Lung Dis 1999; 3: 582-588.
17. Migliori G B, Raviglione M C, Schaberg T, et al. Tuberculosis management in Europe. Recommendations of a Task Force of the European Respiratory Society (ERS), the World Health Organization (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur Respir J 1999; 14: 978-992.
18. Balabanova Y, Fedorin I, Elizarova E, et al. Drug resistance in Samara, as a model of the Russian Federation. Int J Tuberc Lung Dis 2001; 5 (Suppl 1): S69-S70.
19. Shilova M. Tuberculosis in Russia: causes of increasing rates. Int J Tuberc Lung Dis 2001; 5 (Suppl 1): S68.
20. Dimou T, Varela A, Agelopoulos A, et al. Results from 6 years of susceptibility testing of clinical Mycobacterium tuberculosis isolates in South West Greece. Int J Tuberc Lung Dis 2001; 5 (Suppl 1): S80.
21. Shpaner I, Zalyaliev R, Zamaletdinova L, et al. Dynamics of multidrug resistance tuberculosis in Republic of Tatarstan. Int J Tuberc Lung Dis 2001; 5 (Suppl 1): S82.
22. Forssbohm M, Sagebiel D, Hauer B, et al. Drug-resistant tuberculosis in Germany. Int J Tuberc Lung Dis 2001; 5 (Suppl 1): S83-S84.